Filing Details

Accession Number:
0000899243-18-023934
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-06 16:59:27
Reporting Period:
2018-09-04
Accepted Time:
2018-09-06 16:59:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413822 Anastasios Gianakakos C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-04 3,000 $1.51 77,949 No 4 M Direct
Common Stock Disposition 2018-09-04 2,500 $59.21 75,449 No 4 S Direct
Common Stock Disposition 2018-09-04 500 $59.96 74,949 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-09-04 3,000 $0.00 3,000 $1.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
111,254 2025-06-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 85,973 Indirect By Reporting Person's Trust 2
Common Stock 500,000 Indirect By Reporting Person's Trust 3
Common Stock 12,200 Indirect By Trust 1
Common Stock 12,200 Indirect By Trust 2
Common Stock 12,200 Indirect By Trust 3
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Represents the weighted average sale price of the shares sold ranging from $58.65 to $59.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average sale price of the shares sold ranging from $59.80 to $60.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. 25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date.